Alnylam® Pharmaceuticals—The Leading RNAi Therapeutics Company | Canada

Alnylam is leading the translation of RNA interference (RNAi) into a innovative, entirely new class of medicines which we believe have the potential to transform the lives of patients who are living with rare and genetic diseases.

关键词：alnylam, alnylam pharmaceuticals, rnai companies, rnai therapeutics, rna interference, genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, central nervous system diseases, ocul…